| SC 13D/A | 2024-04-15 | SHAH CAPITAL MANAGEMENT | NOVAVAX INC | 9,326,176 | 6.7% | EDGAR |
| SC 13D | 2024-04-15 | SHAH CAPITAL MANAGEMENT | NOVAVAX INC | 9,326,176 | 6.7% | EDGAR |
| SC 13G/A | 2024-03-07 | MORGAN STANLEY | NOVAVAX INC | 2,454,328 | 1.8% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | NOVAVAX INC | 14,560,054 | 12.3% | EDGAR |
| SC 13G | 2024-02-09 | MORGAN STANLEY | NOVAVAX INC | 7,308,033 | 6.2% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | NOVAVAX INC | 8,436,179 | 7.1% | EDGAR |
| SC 13G/A | 2024-01-25 | STATE STREET CORP | NOVAVAX INC | - | 14.1% | EDGAR |
| SC 13G | 2023-08-18 | SK Bioscience Co., Ltd. | NOVAVAX INC | 6,500,000 | 6.4% | EDGAR |
| SC 13G/A | 2023-05-10 | STATE STREET CORP | NOVAVAX INC | - | 12.1% | EDGAR |
| SC 13D | 2023-04-27 | SHAH CAPITAL MANAGEMENT | NOVAVAX INC | 4,550,756 | 5.3% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | NOVAVAX INC | 8,844,653 | 10.4% | EDGAR |
| SC 13G/A | 2023-02-02 | STATE STREET CORP | NOVAVAX INC | - | 7.2% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | NOVAVAX INC | 4,808,261 | 5.7% | EDGAR |
| SC 13G/A | 2022-12-12 | VANGUARD GROUP INC | NOVAVAX INC | 7,992,228 | 10.2% | EDGAR |
| SC 13G/A | 2022-03-11 | BlackRock Inc. | NOVAVAX INC | 4,410,761 | 5.8% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | NOVAVAX INC | 2,097,794 | 2.8% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | NOVAVAX INC | 6,897,007 | 9.1% | EDGAR |
| SC 13G | 2022-02-08 | BlackRock Inc. | NOVAVAX INC | 4,410,761 | 5.8% | EDGAR |
| SC 13G/A | 2021-02-16 | D. E. SHAW & CO, L.P. | NOVAVAX INC | 110,645 | 0.2% | EDGAR |
| SC 13G | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | NOVAVAX INC | 3,788,564 | 6.0% | EDGAR |